Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Gallbladder or Biliary Disease
In August 2025 , Teva Pharmaceutical Industries Ltd announced that the company received U.S
The frequency of administration is crucial, as after seven or eight weeks, the dosage is typically reduced to a monthly schedule
In the UK, SCoMIS has been announced in 2025, a landmark government-funded and IQVIA-run study will enrol thousands of patients, including those from Scotlands most deprived areas, to assess the impact of obesity treatments in real-world settings
Boza JJ, Moennoz D, Bournot CE, Blum S, Zbinden I, Finot PA, Ballevre O
Accompanying symptoms may include: Nausea and vomiting that is persistent and does not respond to usual remedies Possible fever and elevated heart rate Abdominal tenderness when the area is touched Abdominal distension or bloating In severe cases, signs of systemic illness including confusion, shortness of breath, or low blood pressure Diagnosis of acute pancreatitis typically requires at least two of three criteria: characteristic abdominal pain, elevated pancreatic enzymes (lipase or amylase) greater than three times the upper limit of normal, and imaging findings consistent with pancreatic inflammation